STE Stock Overview
STERIS plc provides infection prevention and other procedural products and services worldwide.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$230.71|
|52 Week High||US$255.93|
|52 Week Low||US$188.10|
|1 Month Change||-1.18%|
|3 Month Change||-2.79%|
|1 Year Change||20.86%|
|3 Year Change||73.01%|
|5 Year Change||191.08%|
|Change since IPO||11,085.94%|
Recent News & Updates
|STE||US Medical Equipment||US Market|
Return vs Industry: STE exceeded the US Medical Equipment industry which returned -15.8% over the past year.
Return vs Market: STE exceeded the US Market which returned -15.1% over the past year.
|STE Average Weekly Movement||4.5%|
|Medical Equipment Industry Average Movement||10.5%|
|Market Average Movement||7.8%|
|10% most volatile stocks in US Market||16.8%|
|10% least volatile stocks in US Market||2.9%|
Stable Share Price: STE is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: STE's weekly volatility (5%) has been stable over the past year.
About the Company
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
STERIS Fundamentals Summary
|STE fundamental statistics|
Is STE overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|STE income statement (TTM)|
|Cost of Revenue||US$2.49b|
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
|Earnings per share (EPS)||2.44|
|Net Profit Margin||5.32%|
How did STE perform over the long term?See historical performance and comparison
0.7%Current Dividend Yield
Does STE pay a reliable dividends?See STE dividend history and benchmarks
|STERIS dividend dates|
|Ex Dividend Date||Jun 13 2022|
|Dividend Pay Date||Jun 28 2022|
|Days until Ex dividend||17 days|
|Days until Dividend pay date||32 days|
Does STE pay a reliable dividends?See STE dividend history and benchmarks
Is STERIS undervalued compared to its fair value and its price relative to the market?
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: STE ($230.71) is trading above our estimate of fair value ($142.07)
Significantly Below Fair Value: STE is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: STE is poor value based on its Price-To-Earnings Ratio (94.7x) compared to the US Medical Equipment industry average (35.2x).
PE vs Market: STE is poor value based on its Price-To-Earnings Ratio (94.7x) compared to the US market (15.2x).
Price to Earnings Growth Ratio
PEG Ratio: STE is poor value based on its PEG Ratio (5.1x)
Price to Book Ratio
PB vs Industry: STE is overvalued based on its Price-To-Book Ratio (3.5x) compared to the US Medical Equipment industry average (2.5x).
How is STERIS forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: STE's forecast earnings growth (18.7% per year) is above the savings rate (1.9%).
Earnings vs Market: STE's earnings (18.7% per year) are forecast to grow faster than the US market (13% per year).
High Growth Earnings: STE's earnings are forecast to grow, but not significantly.
Revenue vs Market: STE's revenue (7.9% per year) is forecast to grow slower than the US market (8% per year).
High Growth Revenue: STE's revenue (7.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: STE's Return on Equity is forecast to be low in 3 years time (8.9%).
How has STERIS performed over the past 5 years?
Past Performance Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: STE has a large one-off loss of $82.8M impacting its March 31 2022 financial results.
Growing Profit Margin: STE's current net profit margins (5.3%) are lower than last year (12.8%).
Past Earnings Growth Analysis
Earnings Trend: STE's earnings have grown by 11% per year over the past 5 years.
Accelerating Growth: STE's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: STE had negative earnings growth (-38.6%) over the past year, making it difficult to compare to the Medical Equipment industry average (16.1%).
Return on Equity
High ROE: STE's Return on Equity (3.7%) is considered low.
How is STERIS's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: STE's short term assets ($1.9B) exceed its short term liabilities ($922.2M).
Long Term Liabilities: STE's short term assets ($1.9B) do not cover its long term liabilities ($4.0B).
Debt to Equity History and Analysis
Debt Level: STE's net debt to equity ratio (39.7%) is considered satisfactory.
Reducing Debt: STE's debt to equity ratio has reduced from 52.6% to 45% over the past 5 years.
Debt Coverage: STE's debt is well covered by operating cash flow (23.2%).
Interest Coverage: STE's interest payments on its debt are well covered by EBIT (7.1x coverage).
What is STERIS current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: STE's dividend (0.75%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.54%).
High Dividend: STE's dividend (0.75%) is low compared to the top 25% of dividend payers in the US market (4.01%).
Stability and Growth of Payments
Stable Dividend: STE is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: STE is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Earnings Payout to Shareholders
Earnings Coverage: STE is not paying a notable dividend for the US market.
Cash Payout to Shareholders
Cash Flow Coverage: STE is not paying a notable dividend for the US market.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Dan Carestio (48 yo)
Mr. Daniel A. Carestio, also known as Dan, serves as the Chief Executive Officer & President at STERIS plc since July 29, 2021. He had been Senior Vice President and Chief Operating Officer at STERIS plc s...
CEO Compensation Analysis
Compensation vs Market: Dan's total compensation ($USD2.91M) is below average for companies of similar size in the US market ($USD13.20M).
Compensation vs Earnings: Dan's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Experienced Management: STE's management team is considered experienced (2.8 years average tenure).
Experienced Board: STE's board of directors are considered experienced (6.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.3%.
STERIS plc's employee growth, exchange listings and data sources
- Name: STERIS plc
- Ticker: STE
- Exchange: NYSE
- Founded: 1985
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: US$23.100b
- Shares outstanding: 100.13m
- Website: https://www.steris.com
Number of Employees
- STERIS plc
- 70 Sir John Rogerson’s Quay
- Dublin 2
- Co. Dublin
- D02 R296
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/26 00:00|
|End of Day Share Price||2022/05/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.